Clinical Trial

Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A-PRP (Autologous Platelet Rich Plasma) is becoming widely used in a variety of medical procedures seeking tissue remodeling and/or healing as an intervention. To date, applications in orthopedics, wound healing, dermatology and plastic surgery have gained general acceptance, primarily as the role of platelets and their activation in tissue repair and recovery has become better understood at a cellular and molecular level. This study will involve adult women with a diagnosis of Premature ovarian insufficiency (POI) willing to perform an IVF/ICSI treatment.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-05-07; most recent amendment 2026-06-22.
Status change: Recruiting → Active, Not Recruiting 2023-07-30
Status change: Not Yet Recruiting → Recruiting 2021-10-19
Trial Details
NCT Number NCT04381299
Lead Sponsor ART Fertility Clinics LLC
Conditions Infertility, IVF, Premature Ovarian Failure, Anti-Mullerian Hormone Deficiency
Enrollment 35 participants
Start Date 2021-04-25
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-25